AbbVie's HUMIRAÂ Adalimumab Receives CHMP Positive Opinion to Treat Adolescents with Hidradenitis Suppurativa a Chronic Inflammatory Skin Disease

NORTH CHICAGO Ill. Nov. 14 2016 PRNewswire AbbVie NYSE ABBV a global biopharmaceutical company today announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has granted a positive opinion for HUMIRAÂ ada...